CLN5 and plasma cell myeloma: Previously published findings relating to BMP signalling in myeloma are limited to observations that BMPs are toxic to myeloma cells in vitro11,13,35, that BMPs may increase hepcidin levels and contribute to anaemia36 and that certain ligands and receptors may be increased in myeloma marrow samples, including BMP627,37.